-- Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells
In a 48-week Phase 2 obesity trial, participants on the 12mg dose recorded a mean body-weight reduction of 24.2%, versus 2.1% on placebo[1]. 83% of that group lost 15% or more of their body weight, and 93% lost at least 10%[1]
#fxmedicine #fxmedicinepodcast #lifestylemedicine #naturalmedicine #nutritionalmedicine #naturopathy #naturopathicmedicine #naturopath #complementarymedicine #integrativemedicine #herbalmedicine #autoimmunethyroid #hashimotos #gravesdisease #thyroidhealth #selenium #inositol #vitamind #coq10 #iodine To view or add a comment, sign in 3,900 followers
May 2022 28
Comparative genomics experiments have revealed a high level of genomic diversity that results from intra-genomic diversification (for example, point mutations, recombination, and slipped-strand mispairing), as well as inter-genomic recombination, the ability of H